The US Food and Drug Administration has an approval pathway in mind for unbranded biologics, but sponsors should not send in their applications unannounced.
Can Biosimilars Compete With ‘Unbranded Biologics’ In The US Market?
Biologics with their brand name dropped from the label could become the alternative to an ‘authorized biosimilar,’ which is not allowed under the law.
